Letter From the Editor: Optimizing Interleukin-23 Inhibitor Dosing in Inflammatory Bowel Disease

How can clinicians navigate dose optimization of interleukin (IL)-23 inhibitor therapies in patients with inflammatory bowel disease (IBD)? This question is explored in my Advances in […]

Letter From the Editor: Use of Glucagon-Like Peptide-1 Receptor Agonists Across the Liver Transplant Continuum

This month’s issue of Gastroenterology & Hepatology places a spotlight on the evolving role of glucagon-like peptide-1 receptor agonists (GLP-1RAs) before and after liver transplant (LT). […]

Letter From the Editor: Emerging Therapeutic Advances for Chronic Hepatitis B Virus Infection

With more than 250 million people currently infected with chronic hepatitis B virus (HBV) worldwide, this disease remains a global public health concern and a primary […]

Letter From the Editor: Update on the Management of Pregnant Patients With Inflammatory Bowel Disease

What is new in the management of pregnant patients with inflammatory bowel disease (IBD)? This month’s issue of Gastroenterology & Hepatology explores recent developments involving diagnostics, […]

Letter From the Editor: Exploring the Disease Entity of MetALD

In 2023, MetALD was officially introduced as a disease entity, as part of a broader international, multisociety consensus process. MetALD is a new medical classification for […]

Letter From the Editor: Therapeutic Approaches for Disorders of Gut-Brain Interaction Other Than Medication

This month’s issue of Gastroenterology & Hepatology explores a wide array of current and emerging nonmedical approaches to the treatment of disorders of gut-brain interaction (DGBIs) […]

Letter From the Editor: Nutritional Management of Adult Patients Who Have Crohn’s Disease

How can we best approach the nutritional management of adult Crohn’s disease patients? This month’s issue of Gastroenterology & Hepatology features an Advances in IBD column […]

Letter From the Editor: The Evolving Concept of a Therapeutic Window of Opportunity for Crohn’s Disease

What is the therapeutic window of opportunity in patients with Crohn’s disease? This question is explored in a feature article in this month’s issue of Gastroenterology […]

Letter From the Editor: Spotlight on the Surveillance of Pouches

Is routine surveillance of a pouch always necessary? This question is explored in the Advances in IBD column in this month’s issue of Gastroenterology & Hepatology. […]

Letter From the Editor: The Evolving Field of Interventional Endoscopic Ultrasound

Has the field of interventional endoscopic ultrasound (EUS) reached a plateau? Professor Marc Giovannini, a pioneer of EUS-guided fine-needle aspiration and EUS-guided bilioduodenal anastomosis, attempts to […]

Letter From the Editor: Exploring Current and Emerging Therapies for Patients With Primary Biliary Cholangitis

Up to 40% of patients with primary biliary cholangitis (PBC) do not respond adequately to ursodeoxycholic acid, which is well established for first-line treatment. One of […]

Letter From the Editor: The Wave of Innovation in Endoscopic Bariatric and Metabolic Therapies

The field of endoscopic bariatric and metabolic therapies (EBMTs) is advancing rapidly. This month’s issue of Gastroenterology & Hepatology features an interview in our Advances in […]

Letter From the Editor: Examining the Use of Natural Products for the Treatment of Irritable Bowel Syndrome

Should natural products have a role in the management of patients with irritable bowel syndrome (IBS)? One of the feature articles in this month’s issue of […]

Letter From the Editor: Exploring the Use of Terlipressin in Candidates for Liver Transplant

Should terlipressin be used in liver transplant candidates? This question is explored in a feature article in this month’s issue of the journal Gastroenterology & Hepatology. […]

Letter From the Editor: Exploring Irritable Bowel Syndrome Symptoms in Patients With Inflammatory Bowel Disease

The prevalence of irritable bowel syndrome (IBS) symptoms in patients with inflammatory bowel disease (IBD) can vary greatly—from 11% to 64%, depending on the study population—and […]

Letter From the Editor: Examining Exercise in Metabolic Dysfunction-Associated Steatohepatitis

How and why should patients who have metabolic dysfunction-associated steatohepatitis (MASH) exercise? The MASH in Focus column in this month’s issue of Gastroenterology & Hepatology places […]

Letter From the Editor: Exploring the Use of Digital Therapeutics for Patients With Disorders of Gut-Brain Interaction

Can digital therapeutics such as apps help in the management of patients with disorders of gut-brain interaction? This question is explored in the Advances in IBS […]

Letter From the Editor: Female Representation in Advanced Endoscopy

Just two years ago, women accounted for less than 20% of the advanced fellows who received a match in the American Society for Gastrointestinal Endoscopy (ASGE) […]

Letter From the Editor: Exploring Screening for Colorectal Cancer

How can we best approach screening for colorectal cancer? This month’s issue of the journal Gastroenterology & Hepatology highlights screening for colorectal cancer, which remains one […]

Letter From the Editor: Examining the Use of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis

Last month’s issue of the journal Gastroenterology & Hepatology delved into the use of glucagon-like peptide-1 (GLP-1) receptor agonists in patients with inflammatory bowel disease (IBD). […]